Shares of Moderna slid 6.46% to $137.71 at 15:04 EST on Wednesday, after two sequential sessions in a row of losses. The Nasdaq Stock Market is jumping 0.22% to $12,622.60, after two sequential sessions in a row of gains. This seems, at the moment, a somewhat positive trend exchanging session today.
Moderna’s last close was $147.22, 29.62% under its 52-week high of $178.50.
News about Moderna today
Stocks making the biggest moves in the premarket: tilray, Aphria, penumbra, Moderna & more. According to today’s article on CNBC, "Moderna (MRNA) – Moderna was downgraded to "hold" from "buy" at Jefferies, which cited the significant runup in the drugmaker’s stock as well as high expectations surrounding its Covid-19 vaccine. "
Moderna party ending, analysts caution before shot approval. According to today’s article on Bloomberg Quint, "Moderna’s valuation may be at risk if retail interest wanes as new vaccines become a reality. ", "Moderna’s shot will face a Food and Drug Administration panel on Thursday, and soon after the vaccine is likely to get regulatory clearance."
Moderna’s sales growth is 1428.1% for the current quarter and 13065.3% for the next. The company’s growth estimates for the present quarter is a negative 48.6% and positive 565.7% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s Stock Top and Bottom Yearly Value
Moderna’s stock is valued at $137.71 at 15:04 EST, way below its 52-week high of $178.50 and way above its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s value is way higher than its 50-day moving average of $108.35 and way above its 200-day moving average of $78.59.
Previous days news about Moderna
Moderna says U.S. to buy 100 million additional vaccine doses. According to Bloomberg Quint on Fri Dec 11, "HHS and the Department of Defense have provided $3.2 billion to expand the manufacturing capacity reserved for Moderna’s two-dose vaccine regimen, known as mRNA-1273.", "Moderna shares gained 2.6% in late trading in New York. "
Take-two, occidental petroleum, Moderna: what to watch when the stock market opens today. According to The Wall Street Journal on Tue Dec 15, "-Shares of the vaccine maker Moderna were down 1% premarket. "
Moderna vaccine found safe, effective ahead of key FDA review. According to Bloomberg Quint on Tue Dec 15, "The FDA got a much deeper look at Moderna’s clinical-trial data than the numbers previously released to the public by the company. ", "Moderna’s vaccine will be distributed to sites around the country where health-care workers and residents of long-term care facilities, such as nursing homes, are expected to get the earliest doses."
Moderna vaccine found safe, effective before key FDA review. According to Bloomberg Quint on Tue Dec 15, "The shot must be kept extremely cold and requires special freezers to transport, while Moderna’s can be kept in more traditional cold storage.", "The FDA staff’s analysis of Moderna’s trial data found 11 cases of Covid-19 in the group that received the vaccine and 185 in those that got a placebo instead."
Moderna shares up in premarket as FDA calls Covid-19 vaccine 'highly effective'. According to MarketWatch on Tue Dec 15, "Shares of Moderna Inc. gained 1.5% in premarket trading on Tuesday after the Food and Drug Administration said the company’s COVID-19 vaccine candidate is “highly effective” at preventing infections with the coronavirus. "
Canada to receive early access to Moderna Covid-19 vaccine. According to Business Insider on Tue Dec 15, "Today, the Honourable Anita Anand, Minister of Public Services and Procurement, announced that following successful negotiations and contingent on Health Canada authorization of the vaccine, Canada will be able to access 168,000 doses of the Moderna COVID-19 vaccine in December 2020.", "The Moderna vaccine would be the first delivered through the end-to-end COVID-19 logistics services contract awarded to FedEx Express Canada and Innomar Strategies Inc."
Moderna to offer covid shots to volunteers who got placebo. According to Bloomberg Quint on Tue Dec 15, "Moderna Inc. is preparing to offer its Covid-19 shot to trial participants who received a placebo in the final-stage study once the vaccine is authorized for emergency use in the U.S.", "Ray Jordan, a Moderna spokesman, confirmed the letter was being prepared."